Trial Profile
A Phase 2b, Randomized Study to Evaluate the Efficacy and Safety of Subcutaneous MEDI-528 in Adults With Uncontrolled Asthma.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Enokizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 13 Aug 2012 Actual end date (January 2012) added as reported by ClinicalTrials.gov.
- 20 May 2012 Results reported at the 108th International Conference of the American Thoracic Society.
- 01 Jan 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.